Integra Lifesciences Holdings (IART) Non-Current Deferred Tax Liability (2009 - 2026)

Integra Lifesciences Holdings' Non-Current Deferred Tax Liability history runs 18 years deep, the most recent figure standing at $6.1 million for Q1 2026.

• In Q1 2026, Non-Current Deferred Tax Liability fell 89.33% year-over-year to $6.1 million; the TTM figure through Mar 2026 stood at $6.1 million (down 89.33% YoY), while the FY2025 annual figure was $5.7 million, down 90.69% from the prior year.
• Non-Current Deferred Tax Liability came in at $6.1 million for Q1 2026 at Integra Lifesciences Holdings, up from $5.7 million in the prior quarter.
• In the past five years, Non-Current Deferred Tax Liability ranged from a high of $86.5 million in Q2 2024 to a low of $5.7 million in Q4 2025.
• A 5-year average of $54.6 million and a median of $60.8 million in 2024 frame the typical range for Non-Current Deferred Tax Liability.
• On a YoY basis, Non-Current Deferred Tax Liability climbed as much as 83.2% in 2025 and fell as far as 90.69% in 2025.
• Integra Lifesciences Holdings' Non-Current Deferred Tax Liability stood at $63.3 million in 2022, then plunged by 44.24% to $35.3 million in 2023, then surged by 72.25% to $60.8 million in 2024, then plunged by 90.69% to $5.7 million in 2025, then increased by 8.46% to $6.1 million in 2026.
• According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $6.1 million, $5.7 million, and $58.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison